Treatmybrand


a Kainjoo SA Venture
Ch. du Vernay 14a
1196 Gland
+41.21.561.34.96
info@treatmybrand.com

Support


Monday to Friday
8AM to 8PM
support@treatmybrand.com
Back

US panel warns of China’s biopharma ambitions and supply chain risk

A US commission has urged lawmakers to move quickly to prevent what it calls an “overdependence” on China in the biopharma sector, according to BioPharma Dive. The panel warns that such reliance could make American patients vulnerable if China decides to disrupt supply chains.

This warning signals a strategic risk for pharma and biotech leaders, who may need to review their own supply chain dependencies. The commission’s concerns suggest that sourcing and resilience planning should be a priority for companies with global operations.

BioPharma Dive
BioPharma Dive